Zolenzepine

Application Z36 may be used to study cell signaling that results in autophagy. Biochem/physiol Actions Z36 inhibits cell proliferation and induces death in HeLa cells.

Application Zafirlukast has been used to stimulate pancreatic &#946: cell line (MIN6) and pancreatic islets for insulin secretion assay. It may be used as an adenosine triphosphate-binding cassette transporter (ABCG2) inhibitor in MTT

Application Zafirlukast has been used to stimulate pancreatic &#946: cell line (MIN6) and pancreatic islets for insulin secretion assay. It may be used as an adenosine triphosphate-binding cassette transporter (ABCG2) inhibitor in MTT

Zafirlukast is a leukotriene receptor antagonist (LTRA). (IC50=0.6μM, IC50=7.0 μM for CYP2C9).A potent and selective CysLT1 receptor antagonist.Product description： Zafirlukast is a potent leukotriene D4 (LTD4) receptor antagonist with oral

Zafirlukast is a leukotriene receptor antagonist (LTRA). (IC50=0.6μM, IC50=7.0 μM for CYP2C9).A potent and selective CysLT1 receptor antagonist.Product description： Zafirlukast is a potent leukotriene D4 (LTD4) receptor antagonist with oral

Zafirlukast is a leukotriene receptor antagonist (LTRA). (IC50=0.6μM, IC50=7.0 μM for CYP2C9).A potent and selective CysLT1 receptor antagonist.Product description： Zafirlukast is a potent leukotriene D4 (LTD4) receptor antagonist with oral

InformationZafirlukast (ICI-204219) Zafirlukast (ICI-204219) is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.In vitroZafirlukast is similar to 3-methylindole because it contains an N-methylindole moiety that has a

Product descriptionZAP-180013 is a zeta-chain-associated protein kinase 70 (ZAP-70) inhibitor with an IC50 of 1.8 μM. ZAP-180013 inhibits the interaction of ZAP-70 SH2 domain with immunoreceptor tyrosine-based activation motif (ITAMs).

Product descriptionZAP-180013 is a zeta-chain-associated protein kinase 70 (ZAP-70) inhibitor with an IC50 of 1.8 μM. ZAP-180013 inhibits the interaction of ZAP-70 SH2 domain with immunoreceptor tyrosine-based activation motif (ITAMs).

Product descriptionZAP-180013 is a zeta-chain-associated protein kinase 70 (ZAP-70) inhibitor with an IC50 of 1.8 μM. ZAP-180013 inhibits the interaction of ZAP-70 SH2 domain with immunoreceptor tyrosine-based activation motif (ITAMs).

Product descriptionZAP-180013 is a zeta-chain-associated protein kinase 70 (ZAP-70) inhibitor with an IC50 of 1.8 μM. ZAP-180013 inhibits the interaction of ZAP-70 SH2 domain with immunoreceptor tyrosine-based activation motif (ITAMs).

Product descriptionZAP-180013 is a zeta-chain-associated protein kinase 70 (ZAP-70) inhibitor with an IC50 of 1.8 μM. ZAP-180013 inhibits the interaction of ZAP-70 SH2 domain with immunoreceptor tyrosine-based activation motif (ITAMs).